Related News
Promising breast cancer treatment
Source: Agencies |
June 1, 2009, Monday
|
Print Edition
Print Edition
DRUGS targeting an enzyme known as PARP show promise as treatments for some of the most aggressive and difficult-to-treat forms of breast cancer, according to new research.
The findings were presented yesterday at the annual meeting of the American Society of Clinical Oncology.
Mid-stage results from a PARP inhibitor developed by BiPar Sciences Inc show that it improved survival by 60 percent compared with chemotherapy alone for women with "triple negative breast cancer."
And a small trial of AstraZeneca Plc's olaparib in women with advanced breast cancer linked to genetic mutations showed that it shrank tumors in a third of patients.
PARP is short for "poly (ADP-ribose) polymerase," which is used by cancer cells to repair DNA damage, including the damage inflicted by chemotherapy drugs.
Dr Barry Sherman, head of development at BiPar, presented the results from a 116-patient trial of its intravenous PARP inhibitor, known as BSI-201, which is being studied in women with "triple negative" metastatic breast cancer, a very aggressive form of the disease that has no other treatment beyond chemotherapy.
The findings were presented yesterday at the annual meeting of the American Society of Clinical Oncology.
Mid-stage results from a PARP inhibitor developed by BiPar Sciences Inc show that it improved survival by 60 percent compared with chemotherapy alone for women with "triple negative breast cancer."
And a small trial of AstraZeneca Plc's olaparib in women with advanced breast cancer linked to genetic mutations showed that it shrank tumors in a third of patients.
PARP is short for "poly (ADP-ribose) polymerase," which is used by cancer cells to repair DNA damage, including the damage inflicted by chemotherapy drugs.
Dr Barry Sherman, head of development at BiPar, presented the results from a 116-patient trial of its intravenous PARP inhibitor, known as BSI-201, which is being studied in women with "triple negative" metastatic breast cancer, a very aggressive form of the disease that has no other treatment beyond chemotherapy.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
